Skip to Content

Nepafenac ophthalmic Pregnancy and Breastfeeding Warnings

Nepafenac ophthalmic is also known as: Ilevro, Nevanac

Nepafenac ophthalmic Pregnancy Warnings

Nepafenac ophthalmic has been assigned to pregnancy category C by the FDA. Animal studies have failed to reveal signs of teratogenicity. There have been reports of dystocia, increased post-implantation loss, reduced fetal weights and growth, and reduced fetal survival in rats following dosages of at least 10 mg/kg. There are no controlled data in human pregnancy. Nepafenac ophthalmic is only recommended for use during pregnancy when benefit outweighs risk. Nepafenac ophthalmic should be avoided during late pregnancy due to the possible adverse effects on the fetal cardiovascular system (closure of the ductus arteriosus) reported with nonsteroidal anti-inflammatory agents.

See references

Nepafenac ophthalmic Breastfeeding Warnings

There are no data on the excretion of nepafenac ophthalmic into human milk. The manufacturer recommends that caution be used when administering nepafenac ophthalmic to nursing women.

See references

References for pregnancy information

  1. "Product Information. Nevanac (nepafenac ophthalmic)." Alcon Laboratories Inc, Fort Worth, TX.

References for breastfeeding information

  1. "Product Information. Nevanac (nepafenac ophthalmic)." Alcon Laboratories Inc, Fort Worth, TX.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.